poLight (PLT) ABGSC Investor Days summary
Event summary combining transcript, slides, and related documents.
ABGSC Investor Days summary
4 Dec, 2025Technology and product innovation
Developed a fast, compact, low-power tunable lens technology mimicking the human eye, targeting AR/MR glasses and other applications.
Platform enables products like TLens for autofocus and TWedge for display enhancement in smart glasses.
Scalable production with MEMS-based 'eye muscles' and polymer lens, assembled in Asia.
New lead-free tunable lens and MLens for machine vision to expand product offerings.
Market focus and growth strategy
Main focus is on AR/MR glasses, with six enterprise design wins serving as references for consumer market expansion.
Consumer AR/MR segment is expected to drive significant volume growth, with 21 proof-of-concept projects, mostly consumer-focused.
Industrial applications like barcode reading and machine vision provide higher price points but lower volumes.
Strategic investment from Q Technology, a major camera module supplier, boosts credibility and funding.
Financial outlook and operational plans
Consumer smart glasses market is growing rapidly, with potential volumes reaching up to 10 million units per year.
ASP for consumer market expected to start around $2–2.5, with industrial ASP closer to $10.
Targeting gross margins near 40% for high-volume Tier 1 customers.
Profitability is expected in a few years, with funding scenarios dependent on business plan execution.
Latest events from poLight
- AR/MR and TWedge segments show strong momentum, with investments supporting future growth.PLT
Investor update2 Mar 2026 - Record Q4 revenue and strong AR/MR momentum, with 60% gross margin and robust cash reserves.PLT
Q4 202524 Feb 2026 - AR/MR and industrial momentum grows, cash up, smartphone market remains challenging.PLT
Q2 20241 Feb 2026 - AR/MR and industrial momentum grew despite lower revenue; liquidity boosted by rights issue.PLT
Q1 202431 Jan 2026 - AR/MR and consumer markets prioritized, with new tech and strong pipeline driving growth from 2026.PLT
CMD 202431 Jan 2026 - Revenue fell, but AR/MR and healthcare pipelines grew, backed by strong cash reserves.PLT
Q3 202417 Jan 2026 - Expanding in AR/MR and consumer markets, with strong tech and strategic customer engagement.PLT
Investor Update12 Jan 2026 - AR/MR and industrial segments show strong momentum, with robust financials and expanding PoCs.PLT
Investor Update26 Dec 2025 - Q1 2025 revenue climbed, losses widened, and Q Tech investment boosts AR/MR prospects.PLT
Q1 202523 Dec 2025